Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D)

NCT04187599 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
250
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

CooperVision International Limited (CVIL)

Collaborators